Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. - Wikidata - awgldk - TriplyDB

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

http://www.wikidata.org/entity/Q35028544

about

Pharmaceutical follow-up for patients on rituximab therapy for non-Hodgkin lymphoma: what is the evidence?Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial.Reviewing cancer care team effectiveness.Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.Effects of a nurse-led medication self-management programme in cancer patients: protocol for a mixed-method randomised controlled trial.Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data.Evaluation of the impact of a flowchart-type leaflet for cancer inpatients.The use of capecitabine in daily practice: a study on adherence and patients' experiences Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice.A Systematic Review of Adherence to Oral Antineoplastic Therapies Interventions to promote adherence with oral agents.Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study.Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.Adherence to oral antineoplastic agents by cancer patients: definition and literature review.Adherence and patients' experiences with the use of oral anticancer agents.Improving adherence to oral cancer therapy in clinical practice.Medication adherence to oral cancer therapy: The promising role of the pharmacist.Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer.Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?Medication adherence: A practical measurement selection guide using case studies.Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.The Effect of Structured Education to Patients Receiving Oral Agents for Cancer Treatment on Medication Adherence and Self-efficacy.Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab.Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center

P2860

Q34757945-0BA3D874-7125-4F21-902A-8B7018DE62A3 Q34974434-0F61D01B-81FE-4FDF-B32C-E1254B627919 Q35625669-535E645E-E05D-440B-AD5E-2C051ED15A40 Q35682644-55DC7270-559F-4373-8972-AB0805E0F80F Q35917917-5914A545-833A-467D-BF9E-6B9D857D417C Q36030885-6AE3D0AC-22FE-443D-BCDB-B1CAC16149D2 Q36165917-002FDA72-0D59-4165-A9C4-5D63D5FDB94C Q36358178-047B3260-5A34-498F-9429-E4996B3F376A Q36650721-BC65F1E5-4D64-4CBF-B7B7-19A1D2E5894B Q36673490-9C35F6F7-A75D-462F-A51B-43B002DE20EF Q36841396-A640C94C-D777-4B93-9B41-967ECB0C0ED0 Q37029891-4242361E-D36C-48EB-AB3E-D3C664871979 Q37270640-13945465-EFAE-4230-ACC7-E6C45FAC9ED1 Q37273881-E8D9EFD1-B975-44F2-B645-5FD41619AE32 Q37965653-865376AF-A704-4DB4-8C93-795E2172C88B Q38147533-866A7232-E4E8-49A4-986A-BD5724AEB3FF Q38165220-55C30C39-912F-4F9E-A477-6B486D80353D Q38216035-E24D9357-4C53-4E05-BB2B-C58974A2368D Q38266160-D00F9B91-2687-482E-A82F-52C99E4D722B Q38637908-DEFF4BD6-94DC-44BD-BDD8-17906E09FAD7 Q38783329-E92F08C2-0874-4A46-AD2C-380F609F916C Q38887454-46F43D41-3BB4-4A11-9ACF-A52914C2EDB2 Q38954197-EDA5977C-A004-484E-AA65-FCAB64A0C3B0 Q39666516-1E2336FA-32DE-4A57-AF88-D62CD40A7AB9 Q42138629-DEB723C9-1F02-4512-BB81-16A0145B38A7 Q51746862-D5F015B5-271A-4B16-9DB7-6A9EC3CFAC8E Q55311510-62FD50EB-B418-44EB-8937-2C2DCC780DF0 Q57071452-91332426-F70B-4776-B757-11339D868A2C

P2860

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

http://www.wikidata.org/entity/Q35028544

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@ast

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@en

type

label

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@ast

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@en

prefLabel

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@ast

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@en

P1433

Q35028544-DB5CAF09-866A-4074-847A-FB337241F93E

P1476

Q35028544-00156EE2-7C4C-401E-B7D7-450300D5F484

P2093

Q35028544-12C00D6E-03D8-41B2-A98E-FC6FB29C2447

Q35028544-1CFC4C65-A8C7-43DC-9E50-DA08312051F4

Q35028544-33577767-1DD6-4580-A32A-50E7819AED62

Q35028544-34212ED0-9892-4238-8165-DF2713CDC583

Q35028544-447001A4-A072-4D03-8476-685F6E5B99F6

Q35028544-5F02271F-B804-4301-823C-543134233EDB

Q35028544-6E78751A-C5DF-4169-A052-30BF253833A9

Q35028544-DC7F860E-5F57-4B16-B54B-208B1D82B339

Q35028544-DE9BA7D1-E869-41F8-8BA9-37306B5A133B

P2860

Q35028544-06B86EC3-9F85-4024-8F5C-A1D1CD747884

Q35028544-4756F4ED-DAAB-4CBE-B9F5-D19B55B5FC7A

Q35028544-542B7137-3265-4367-A655-84DDEA45D27C

Q35028544-5488DE5A-BC70-4924-910A-F36A2BA657B3

Q35028544-577E3CAC-132D-411C-BAD5-5C5C4877678A

Q35028544-6E2B0E1D-61E7-4E9E-9437-4016D65543FD

Q35028544-7A0BDA6B-0864-463D-9FEA-5A2E3CFB7031

Q35028544-84B6E1E5-843C-4A4B-9139-754897638BD5

Q35028544-924EB3FB-E2D3-4931-95D5-70CC468217E4

Q35028544-92F81820-7C3D-42CE-B16A-9F565E4264B7

P2888

Q35028544-5F3D3AFB-EB9E-4287-B0FD-1D38A95896FF

P304

Q35028544-0E174AF3-03FD-486A-B386-3BBEAEF1B52D

P31

Q35028544-0524BFAE-66BD-4B22-8D1A-2C16BEE73F82

P356

Q35028544-15C5C332-EAF1-4562-80DE-1D2925F54D8C

P433

Q35028544-14AD72EE-D9C1-4A67-A559-056B790E684D

P478

Q35028544-F1A33C7B-81BB-45B6-B03E-35897CEE675B

P577

Q35028544-4B2662C8-65E1-458F-90BA-582E651495B5

P5875

Q35028544-B1F00FE3-CE86-4422-9465-6EB162A01D38

P698

Q35028544-26540003-32F3-4FD3-9DD0-0C8BBD99D20F

P921

Q35028544-55BCD798-9675-48F3-A5DE-D20E9F56F6C9

P932

Q35028544-80E77139-356C-49A0-B04F-83C567DAA7FF

P356

S00520-010-0927-5

P1433

Supportive Care in Cancer

P1476

Enhancing adherence to capecit ...... ciplinary pharmaceutical care.

@en

P2093

Ingo Schmidt-Wolf

http://www.w3.org/2001/XMLSchema#string

Michael Braun

http://www.w3.org/2001/XMLSchema#string

Peter F Schwindt

http://www.w3.org/2001/XMLSchema#string

Susanne Ringsdorf

http://www.w3.org/2001/XMLSchema#string

Sven Simons

http://www.w3.org/2001/XMLSchema#string

Ulrich J Mey

http://www.w3.org/2001/XMLSchema#string

Ulrich Jaehde

http://www.w3.org/2001/XMLSchema#string

Walther Kuhn

http://www.w3.org/2001/XMLSchema#string

Yon D Ko

http://www.w3.org/2001/XMLSchema#string

P2860

Developing and evaluating complex interventions: the new Medical Research Council guidance

Adherence to Medication

Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.

Adjuvant chemotherapy in older women with early-stage breast cancer.

A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research.

The vital role of education and information in patients receiving capecitabine (Xeloda).

Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer.

Capecitabine: a review.

P2888

s00520-010-0927-5

P304

1009-1018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-010-0927-5

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44677344

http://www.w3.org/2001/XMLSchema#string

P698

20552377

http://www.w3.org/2001/XMLSchema#string

P921

P932

3109264

http://www.w3.org/2001/XMLSchema#string